February 18, 2019
Three companies that snagged approval late last week for generic versions of AstraZeneca’s asthma treatment Symbicort (budesonide + formoterol) - Toa Pharmaceuticals, Nipro, and Nihon Generic - codeveloped their copies to join the difficult-to-enter respiratory inhaler market, Jiho has learned...read more